AU2016904621A0 - Improved uses of new formulations - Google Patents

Improved uses of new formulations

Info

Publication number
AU2016904621A0
AU2016904621A0 AU2016904621A AU2016904621A AU2016904621A0 AU 2016904621 A0 AU2016904621 A0 AU 2016904621A0 AU 2016904621 A AU2016904621 A AU 2016904621A AU 2016904621 A AU2016904621 A AU 2016904621A AU 2016904621 A0 AU2016904621 A0 AU 2016904621A0
Authority
AU
Australia
Prior art keywords
new formulations
improved uses
improved
formulations
new
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2016904621A
Inventor
Jamie Hughes
Cris Popp
Bradley Wardrop-Brown
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Grunbiotics Pty Ltd
Original Assignee
Grunbiotics Pty Ltd
Filing date
Publication date
Application filed by Grunbiotics Pty Ltd filed Critical Grunbiotics Pty Ltd
Publication of AU2016904621A0 publication Critical patent/AU2016904621A0/en
Priority to CN201780064352.5A priority Critical patent/CN109843270A/en
Priority to CA3040307A priority patent/CA3040307A1/en
Priority to AU2017346941A priority patent/AU2017346941A1/en
Priority to US16/341,182 priority patent/US20200038318A1/en
Priority to PCT/AU2017/051149 priority patent/WO2018071988A1/en
Priority to EP17863183.4A priority patent/EP3512507A4/en
Abandoned legal-status Critical Current

Links

AU2016904621A 2016-10-20 2016-11-14 Improved uses of new formulations Abandoned AU2016904621A0 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
CN201780064352.5A CN109843270A (en) 2016-10-20 2017-10-20 Oral drug preparation
CA3040307A CA3040307A1 (en) 2016-10-20 2017-10-20 Oral medication formulations
AU2017346941A AU2017346941A1 (en) 2016-10-20 2017-10-20 Oral medication formulations
US16/341,182 US20200038318A1 (en) 2016-10-20 2017-10-20 Oral medication formulations
PCT/AU2017/051149 WO2018071988A1 (en) 2016-10-20 2017-10-20 Oral medication formulations
EP17863183.4A EP3512507A4 (en) 2016-10-20 2017-10-20 Oral medication formulations

Publications (1)

Publication Number Publication Date
AU2016904621A0 true AU2016904621A0 (en) 2016-11-24

Family

ID=

Similar Documents

Publication Publication Date Title
EP3582755A4 (en) Formulations
EP3509581A4 (en) Formulations of (r
EP3270960A4 (en) Vector formulations
EP3166574A4 (en) Cosmetic compositions
EP3096759A4 (en) Modified release formulations of pridopidine
EP3193888A4 (en) Novel formulations
EP3102555A4 (en) Compositions of compounds and uses thereof
EP3457851A4 (en) Derivatives of sobetirome
EP3523274A4 (en) Formulations for administration of eflornithine
EP3206486A4 (en) Pesticide formulations having physical mode of action
EP3280398A4 (en) Self-emulsifying formulations of dim-related indoles
EP3110891A4 (en) Low-voc compositions and methods of making and using the same
EP3384921A4 (en) New use of thiopeptin
EP3554470A4 (en) Cosmetic compositions
EP3297619A4 (en) Therapeutic uses of l-4-chlorokynurenine
EP3237412A4 (en) Solid dispersion formulations of antiviral compounds
EP3478296A4 (en) Phosopholipid compositions
EP3394072A4 (en) Cortistatin analogs and uses thereof
EP3313520A4 (en) Therapeutic uses of berberine formulations
IL272857A (en) Formulations of copanlisib
EP3402463A4 (en) Formulations of vancomycin
EP3373928A4 (en) Novel formulations
EP3265177A4 (en) Formulations of hydrophilic compounds
EP3171860A4 (en) Solid oral formulation of fenretinide
EP3721889A4 (en) Use of butyribacter intestini